Cytosorbents CorporationCTSONASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-2.17%
↓ 117% below average
Average (39q)
13.05%
Historical baseline
Range
High:192.43%
Low:-60.19%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -2.17% |
| Q2 2025 | 9.77% |
| Q1 2025 | -33.95% |
| Q4 2024 | 108.66% |
| Q3 2024 | -30.74% |
| Q2 2024 | -5.39% |
| Q1 2024 | 37.42% |
| Q4 2023 | 9.93% |
| Q3 2023 | -24.40% |
| Q2 2023 | 10.32% |
| Q1 2023 | -5.24% |
| Q4 2022 | 192.43% |
| Q3 2022 | -60.19% |
| Q2 2022 | -12.43% |
| Q1 2022 | -29.45% |
| Q4 2021 | 24.30% |
| Q3 2021 | -25.61% |
| Q2 2021 | 17.09% |
| Q1 2021 | -21.60% |
| Q4 2020 | 28.19% |
| Q3 2020 | 17.30% |
| Q2 2020 | 8.66% |
| Q1 2020 | 27.79% |
| Q4 2019 | 12.00% |
| Q3 2019 | 0.40% |
| Q2 2019 | 41.51% |
| Q1 2019 | -16.23% |
| Q4 2018 | 11.08% |
| Q3 2018 | -11.85% |
| Q2 2018 | 20.73% |
| Q1 2018 | -5.44% |
| Q4 2017 | 56.88% |
| Q3 2017 | 23.93% |
| Q2 2017 | 16.17% |
| Q1 2017 | 1.98% |
| Q4 2016 | 11.62% |
| Q3 2016 | 20.38% |
| Q2 2016 | 25.90% |
| Q1 2016 | 12.46% |
| Q4 2015 | 59.89% |